MACQUARIE GROUP LTD - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,445
-19.7%
1,4730.0%0.00%
Q2 2023$14,259
+29.6%
1,473
+322.1%
0.00%
Q3 2022$11,000
-26.7%
349
-77.1%
0.00%
Q2 2022$15,000
-21.1%
1,5240.0%0.00%
Q1 2022$19,000
-84.7%
1,524
-71.8%
0.00%
Q4 2021$124,000
+376.9%
5,408
+360.3%
0.00%
Q3 2021$26,0001,1750.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders